3.9 Article

Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat

Journal

REGULATORY PEPTIDES
Volume 184, Issue -, Pages 54-61

Publisher

ELSEVIER
DOI: 10.1016/j.regpep.2013.03.005

Keywords

Felodipine plus puerarin; Goldblatt rat; Blood pressure; Heart rate; ACE2/Ang (1-7)/Mas axis; Renal interstitial fibrosis

Funding

  1. Natural Science Foundation of Anhui Province [070413124]
  2. Fresh Start Foundation of Wannan Medical College [BK00010804]

Ask authors/readers for more resources

This study aimed to investigate the effect of combination of felodipine + puerarin on ACE2-Ang (1-7)-Mas axis, and to explore the protective effect of the combination against kidney in renovascular hypertensive rats. Goldblatt rats were randomly divided into 5 groups as follows: 4 groups which were treated with felodipine (Felo), puerarin (Pue), Feb + Pue, and Feb + captopril (Cap), respectively, and a control group of animals that were administrated with distilled water. Contents of Ang II and Ang (1-7) in renal tissues were determined by ELISA kit. The mRNA expression of ACE2/Mas and ACE/AT(1) in kidneys was analyzed by RT-PCR. After 8 weeks of treatment, compared with Goldblatt group, Feb + Pue reduced SBP, DBP and HR (p < 0.01 or p < 0.05), ameliorated renal interstitial fibrosis, decreased the level of Ang II and increased that of Ang (1-7), upregulated mRNA expression of ACE2 and Mas, decreased that of ACE and AT(1), and downregulated protein expression of TGF-beta(1) in kidneys (p < 0.01). Compared with Feb group, Feb + Pue decreased DBP and HR more markedly, attenuated fibrosis, decreased Ang II levels and increased those of Ang (1-7), upregulated mRNA expression of ACE2 in bilateral kidneys and that of Mas in ischemic kidney, downregulated that of ACE in bilateral kidneys and that of AT(1) in ischemic kidney, and decreased expression of TGF-beta(1) protein significantly. In a word, a combination of Feb + Pue has a more efficient therapeutic effect on DBP and HR, and contributes to a better protection against renal interstitial fibrosis. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available